HEPA CIK: 1583771

Hepion Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−31.2
FY22:
−35.0
FY23:
−40.9
FY24:
−18.2
FY25:
−3.27
Change from FY21 to FY25
millions USD
FY21:
−0.13
FY22:
−0.01
FY23:
−0.01
FY24:
−0.60
FY25:
−0.13
Change from FY21 to FY25
millions USD
FY21:
82.0
FY22:
−5.14
FY23:
4.49
FY24:
4.35
FY25:
4.83
millions USD
FY21:
50.6
FY22:
−40.2
FY23:
−36.4
FY24:
−14.4
FY25:
1.42
(positive)
Change from FY21 to FY23
millions USD
FY21:
−31.4
FY22:
−35.0
FY23:
−40.9
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR